Celecoxib shown effective in preventing colon polyps.
Nelson
Nancy J
NJ
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000494:pharmacology; D016588:Anticarcinogenic Agents / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D000068579:Celecoxib; D003111:Colonic Polyps / Q000517:prevention & control*; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D007783:Lactones / Q000009:adverse effects / Q000494:pharmacology; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000139:chemically induced; D009316:National Institutes of Health (U.S.); D011720:Pyrazoles / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012109:Research Support as Topic; D020521:Stroke / Q000139:chemically induced; D013449:Sulfonamides / Q000009:adverse effects* / Q000494:pharmacology* / Q000627:therapeutic use; D013450:Sulfones / Q000009:adverse effects / Q000494:pharmacology; D014481:United States
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016588:Anticarcinogenic Agents; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib